Why the study?
Carney Complex complicated by pseudomyxoma peritonei of lower gastrointestinal origin is extremely rare and poses a significant challenge for clinical diagnosis and multidisciplinary management.
This case demonstrates that advanced Carney Complex with a PRKAR1A mutation can expand beyond mesenchymal tumors to include occult gastrointestinal epithelial mucinous tumors (pseudomyxoma peritonei) alongside ultra-rapid recurrence of cardiac myxoma, necessitating lifelong multidisciplinary management.
Answers are grounded in this paper and cite their sources.
May prompt broader tumor surveillance in Carney complex; leaves open neoplastic lineage expansion to GI epithelia as a general feature.
Carney Complex (CNC) is an extremely rare autosomal dominant hereditary multiple tumor syndrome characterized by skin pigmentation, cardiac and mucocutaneous myxomas, and endocrine adenomas. However, Carney Complex (CNC) complicated by pseudomyxoma peritonei (PMP) of lower gastrointestinal origin is extremely rare, posing a significant challenge for clinical diagnosis and multidisciplinary management. This report presents the complete diagnostic and treatment process of a young female CNC patient with a PRKAR1A gene mutation, aiming to thoroughly explore the diagnostic key points and individualized treatment strategies for this atypical, aggressive disease progression. The patient had a history of recurrent multisystem tumors and surgeries spanning more than a decade (including the eye, heart, breast, and adrenal glands) and was admitted to the hospital due to sudden acute abdominal symptoms. Preoperative imaging revealed a pelvic mass with massive effusion, and tumor markers (CEA, CA199) were abnormally elevated. Following surgical exploration and complete resection of the lesions, histopathology and immunohistochemistry (CK20+/CDX-2+/SATB-2+, PAX-8-/WT-1-) confirmed a low-grade mucinous tumor of lower gastrointestinal origin; however, the appendix showed only acute superficial inflammation, and the primary site remained highly occult, leading to a final diagnosis of PMP.Furthermore, during short-term postoperative follow-up, the patient experienced another “accelerated” malignant recurrence of cardiac myxoma (the fifth recurrence, occurring less than one year after the previous surgery). This case highlights that, in the advanced stages of CNC, its neoplastic lineage may expand across mesenchymal tissue to tumors of gastrointestinal epithelial origin. In the face of such highly complex, rare, and multifocal malignant tumors, the full-lifecycle involvement of a multidisciplinary team (MDT) is crucial for determining the optimal timing of surgery, assessing the risk of recurrence, and improving long-term patient survival. Future research should focus on the molecular mechanisms by which PRKAR1A mutations drive mucinous metaplasia in the gastrointestinal tract.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: